Acta Cytologica最新文献

筛选
英文 中文
Updates on Soft Tissue Cytopathology: Focusing on New and Provisional Entities, Distinct Types, New Diagnostic Tools, and Evolving Concepts. 软组织细胞病理学的更新:关注新的和临时的实体,不同的类型,新的诊断工具和不断发展的概念。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-09-07 DOI: 10.1159/acy/abjag008
Bharat Rekhi, Xiaohua Qian, Andrew S Field
{"title":"Updates on Soft Tissue Cytopathology: Focusing on New and Provisional Entities, Distinct Types, New Diagnostic Tools, and Evolving Concepts.","authors":"Bharat Rekhi, Xiaohua Qian, Andrew S Field","doi":"10.1159/acy/abjag008","DOIUrl":"10.1159/acy/abjag008","url":null,"abstract":"<p><strong>Background: </strong>The first edition of the World Health Organization (WHO) reporting system for soft tissue cytopathology (WHO system) has been released recently, providing a framework of 6 categories with their individual risk of malignancies. The 6th edition of the WHO tumours of soft tissue and bone is in the pipeline, including \"provisional\" tumour entities, reflecting developments in the identification of new entities, particularly based on high-throughput molecular techniques and immunohistochemical stains, including surrogates to the underlying molecular signatures, along with an evolution of tumour concepts.</p><p><strong>Summary: </strong>This review focuses on some of these recently identified and provisional soft tissue tumours; newly described immunohistochemical stains and concepts. The cytopathological features of various soft tissue tumours discussed in this include sarcomas with BCOR alterations, CIC rearranged sarcomas, pseudoendocrine sarcoma, MYOD1-positive spindle cell/sclerosing rhabdomyosarcoma, superficial CD34-positive pleomorphic fibroblastic tumour, pseudomyogenic haemangioendothelioma, chondroid synoviocytic neoplasm, and others.</p><p><strong>Key messages: </strong>This would contribute to the expanding and evolving cytopathological spectrum of soft tissue tumours, including sarcomas, including the value addition of certain more specific immunostains and molecular tests.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148904903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Cytology in Transformation. 转化中的肺细胞学。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-09-05 DOI: 10.1159/acy/abjag007
Jumpei Kashima, Magdalena M Brune, Nikolaus Deigendesch, Spasenija Savic Prince, Obinna Chijioke, Eva Darai-Ramqvist, Lukas Bubendorf
{"title":"Pulmonary Cytology in Transformation.","authors":"Jumpei Kashima, Magdalena M Brune, Nikolaus Deigendesch, Spasenija Savic Prince, Obinna Chijioke, Eva Darai-Ramqvist, Lukas Bubendorf","doi":"10.1159/acy/abjag007","DOIUrl":"10.1159/acy/abjag007","url":null,"abstract":"<p><strong>Background: </strong>Traditionally, pulmonary cytology has been used to diagnose and screen for a variety of respiratory diseases, including lung cancer. Owing to its rapid turnaround time compared with histological diagnosis, therapeutic decisions may occasionally need to be made based on cytological findings alone. In the era of precision medicine, however, biomarker assessment and molecular testing have become increasingly important, particularly in the management of lung cancer. In addition, the digitalization of pathological slides has facilitated the development of artificial intelligence (AI)-based diagnostic tools. The utility of these emerging technologies in pulmonary cytology is currently being actively investigated and continues to evolve, overcoming challenges including low input of tumor cells and the three-dimensional nature of cytological specimens.</p><p><strong>Summary: </strong>This review summarizes recent advances in pulmonary cytology, focusing on immunocytochemistry (ICC), proteomic analysis, and AI-assisted diagnostics. ICC provides crucial information not only for subclassification but also for the assessment of relevant therapeutic biomarkers. Proteomic analysis enables comprehensive characterization of thousands of protein expression profiles simultaneously, using limited cytology materials. But its future use in routine diagnostics must be established and tested in clinical trials. Furthermore, digitalized cytological slides can be utilized for AI-based analyses, potentially reducing diagnostic workload and providing additional predictive information. Despite these advances, challenges remain regarding specimen preparation, standardization, and validation.</p><p><strong>Key messages: </strong>The integration of morphology with appropriately validated molecular and computational methods has the potential to transform the framework of pulmonary cytology, extending its role from morphological diagnosis toward comprehensive and clinically significant characterization of pulmonary tumors.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148896302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Significance of Cell Clusters in Voided Urine in SurePath and ThinPrep Liquid-Based Cytology. 用SurePath和ThinPrep液基细胞学检测空尿细胞簇的诊断意义。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-09-01 DOI: 10.1159/acy/abjag005
Yumiko Higuchi, Toshihiko Kato, Mei Oshima, Fuki Endo, Tomonari Toyama, Shiro Sugihara, Sotaro Kayano, Yasuo Imai
{"title":"Diagnostic Significance of Cell Clusters in Voided Urine in SurePath and ThinPrep Liquid-Based Cytology.","authors":"Yumiko Higuchi, Toshihiko Kato, Mei Oshima, Fuki Endo, Tomonari Toyama, Shiro Sugihara, Sotaro Kayano, Yasuo Imai","doi":"10.1159/acy/abjag005","DOIUrl":"10.1159/acy/abjag005","url":null,"abstract":"<p><strong>Introduction: </strong>Diagnostic significance of cell clusters (CCs) appearing in voided urine cytology remains unclear. Epithelial malignancy tends to form large clusters, but tumor cells get discohesive and clusters become smaller with disease progression. We investigated the diagnostic significance of CCs in the differentiation between low-grade urothelial carcinoma (LGUC) and high-grade urothelial carcinoma (HGUC) and then HGUC detection.</p><p><strong>Methods: </strong>In this study, voided urine samples, suspected of new-onset bladder cancer, with corresponding pathological diagnosis were analyzed. Malignancy other than urothelial carcinoma was excluded. Specimens prepared by the SurePath and ThinPrep liquid-based cytology methods were analyzed separately. Cytological diagnosis was based on The Paris System 2.0, and maximal CC size was measured. These data were subject to statistical analysis.</p><p><strong>Results: </strong>123 SurePath and 168 ThinPrep cases were analyzed in this study. Cytological diagnosis was significantly associated with pathological diagnosis in both SurePath and ThinPrep specimens. Then, CC was found to be present in approximately 60% of specimens prepared by both methods. There was no significant difference in CC size among benign lesions, LGUC, and HGUC in both SurePath and ThinPrep specimens. Meanwhile, high-risk cytology which consists of suspicious for HGUC and HGUC based on TPS 2.0 demonstrated similarly high specificity and positive-predictive value for HGUC detection irrespective of CC presence/absence, but sensitivity was significantly higher when CC was present in both SurePath and ThinPrep specimens.</p><p><strong>Conclusion: </strong>Size of CC was not useful for differentiating LGUC from HGUC, but CC presence was advantageous for detecting HGUC possibly due to a sufficient amount of collected cells for diagnosis.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148872454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Threshold-Dependent Diagnostic Performance of Fine-Needle Aspiration Cytology in Parotid Tumors: A Milan System-Based Analysis. 腮腺肿瘤细针穿刺细胞学阈值依赖性诊断性能:米兰系统为基础的分析。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-08-31 DOI: 10.1159/acy/abjag001
Seval Akay, Ozlem Yagiz Agayarov, Sercan On, Volkan Semiz, Ulku Kucuk, Ilker Burak Arslan, Dudu Solakoglu Kahraman, Ibrahim Cukurova, Olcun Umit Unal
{"title":"Threshold-Dependent Diagnostic Performance of Fine-Needle Aspiration Cytology in Parotid Tumors: A Milan System-Based Analysis.","authors":"Seval Akay, Ozlem Yagiz Agayarov, Sercan On, Volkan Semiz, Ulku Kucuk, Ilker Burak Arslan, Dudu Solakoglu Kahraman, Ibrahim Cukurova, Olcun Umit Unal","doi":"10.1159/acy/abjag001","DOIUrl":"10.1159/acy/abjag001","url":null,"abstract":"<p><strong>Introduction: </strong>Fine-needle aspiration cytology (FNAC) is routinely used in the preoperative evaluation of parotid gland tumors, yet its diagnostic performance varies across categories of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC). This study evaluated category-specific malignancy risk and the clinical impact of different diagnostic thresholds.</p><p><strong>Methods: </strong>We retrospectively analyzed 277 patients who underwent parotidectomy with available preoperative FNAC. Cytologic diagnoses were classified according to the MSRSGC and correlated with final histopathology. Diagnostic performance was assessed using two thresholds: Milan V-VI and Milan III-VI. Trends in malignancy risk across Milan categories were examined, and false-negative and false-positive cases were reviewed by histopathological subtype. Overall discriminatory performance was evaluated using receiver operating characteristic analysis.</p><p><strong>Results: </strong>Final histopathology revealed benign disease in 85.2% and malignancy in 14.8% of cases. Malignancy risk increased significantly across higher Milan categories (p = 0.006). Using Milan V-VI as the threshold yielded high specificity (97.0%) and negative predictive value (88.8%) but low sensitivity (29.3%). Expanding the threshold to Milan III-VI increased sensitivity (78.0%) but markedly reduced specificity (21.2%). Discriminatory performance was poor (AUC 0.622). False-negative results were mainly low-grade malignancies, particularly low-grade mucoepidermoid carcinoma, whereas false-positive results were largely benign oncocytic or hypercellular lesions.</p><p><strong>Conclusion: </strong>FNAC provides useful preoperative risk stratification for parotid gland tumors within the Milan framework, but its diagnostic value is highly threshold-dependent and limited by tumor biology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148863024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scrape Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma of the Sinonasal Tract Masquerading as Schneiderian Papilloma: A Case Report. 伪装为施耐德乳头状瘤的鼻窦炎DEK::AFF2融合相关乳头状鳞状细胞癌的刮刮细胞学分析1例。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-08-17 DOI: 10.1159/acy/abjag004
Hidetoshi Satomi, Keiichiro Honma, Yoji Kukita, Minako Ashimura, Yuki Koyanagi, Yoshinori Kodama, Satoshi Tanada
{"title":"Scrape Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma of the Sinonasal Tract Masquerading as Schneiderian Papilloma: A Case Report.","authors":"Hidetoshi Satomi, Keiichiro Honma, Yoji Kukita, Minako Ashimura, Yuki Koyanagi, Yoshinori Kodama, Satoshi Tanada","doi":"10.1159/acy/abjag004","DOIUrl":"10.1159/acy/abjag004","url":null,"abstract":"<p><strong>Introduction: </strong>DEK::AFF2 fusion-associated papillary squamous cell carcinoma is a recently characterized sinonasal neoplasm that closely mimics Schneiderian papilloma. Although one report has described fine-needle aspiration cytology of a metastatic lymph node, scrape cytological features from the primary site remain undocumented.</p><p><strong>Case presentation: </strong>We report the scrape cytology of this tumor in a 26-year-old woman. While certain features (perivascular arrangement and intracytoplasmic nuclear debris-like structures) overlapped with Schneiderian papilloma, several findings diverged: a predominantly discohesive pattern, nuclear enlargement with anisonucleosis, prominent nucleoli, stippled chromatin distinct from the neuroendocrine pattern, and a crackled cytoplasmic appearance. Immunohistochemistry for synaptophysin and chromogranin A was negative, excluding neuroendocrine differentiation. CD163 immunohistochemistry confirmed that the debris-containing cells were not histiocytes. E-cadherin showed heterogeneous downregulation in the initial biopsy, suggesting a candidate molecular basis for the discohesive pattern. The diagnosis was confirmed by AFF2 immunohistochemistry, DEK break-apart fluorescence in situ hybridization, and reverse transcription polymerase chain reaction with Sanger sequencing. Retrospective AFF2 immunohistochemistry of the initial biopsy, originally diagnosed as Schneiderian papilloma, was positive. The patient remained free of disease progression 34 months after completion of chemoradiotherapy for the antecedent lacrimal sac carcinoma.</p><p><strong>Conclusion: </strong>These findings provide the first comprehensive cytological documentation of this entity from a primary sinonasal site and delineate features diverging from Schneiderian papilloma that may prompt ancillary investigations.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148786805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical Glandular Cell-Not Otherwise Specified and AGC-Favor Neoplastic: Does This Subcategorization Remain Necessary for Triage Cytology? AGC-非特异性和AGC-有利于肿瘤性:这种亚分类对细胞学分类仍然是必要的吗?
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-08-03 DOI: 10.1159/acy/abjag002
Massimo Confortini, Stephanie Pacella, Alessandra Mongia, Giampaolo Pompeo
{"title":"Atypical Glandular Cell-Not Otherwise Specified and AGC-Favor Neoplastic: Does This Subcategorization Remain Necessary for Triage Cytology?","authors":"Massimo Confortini, Stephanie Pacella, Alessandra Mongia, Giampaolo Pompeo","doi":"10.1159/acy/abjag002","DOIUrl":"10.1159/acy/abjag002","url":null,"abstract":"","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148668074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maximizing Cytologic Specimen Supernatants: A New Player in the Molecular Toolbox. 最大化细胞学标本上清液:分子工具箱中的新玩家。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-08-03 DOI: 10.1159/acy/abjag003
Jonas J Heymann, Sinchita Roy-Chowdhuri
{"title":"Maximizing Cytologic Specimen Supernatants: A New Player in the Molecular Toolbox.","authors":"Jonas J Heymann, Sinchita Roy-Chowdhuri","doi":"10.1159/acy/abjag003","DOIUrl":"10.1159/acy/abjag003","url":null,"abstract":"<p><strong>Background: </strong>Multiple cytologic preparations are available to cytopathologists to use for molecular testing (MT). Proper use of each is necessary to improve patient outcomes. Residual cytology specimens and cytology specimen supernatants (CSSs) are novel sources from which nucleic acid may be extracted for MT. CSSs may be of particular interest to the cytology community, as it is routinely discarded. If repurposed for MT instead, it may allow pathologists to preserve cellular material from traditional preparations for other ancillary studies.</p><p><strong>Summary: </strong>To evaluate the utility of CSS, it is first necessary to understand the metrics by which MT is evaluated. These include nucleic acid quantity and tumor percentage, the latter of which may be difficult to precisely quantify in CSS. Metrics of nucleic acid quantity include direct measures, such as degradation value (measure of nucleic acid fragmentation), and indirect measures, including many sequencing-derived metrics and concordance with formalin-fixed, paraffin-embedded tissue or cell blocks. Specimen contamination and turnaround time (TAT) are also critical for patient care. Human papillomavirus testing on residual cytology specimens serves as a model of the clinical utility of MT. More recently, studies have examined both the analytic and clinical value of a broad range of MTs performed on CSS derived from both exfoliative and fine needle aspiration cytology specimens and from specimens collected with and without fixative. These studies have demonstrated that CSS contains both cellular (genomic) and cell-free nucleic acid and that its great advantages lie in reductions in specimen contamination and improvements in TAT. Variations in nucleic acid quantity and quality among studies suggest that further specimen optimization is desirable as CSS becomes more widely adopted as a source of nucleic acid.</p><p><strong>Key messages: </strong>CSSs are no longer considered \"waste\" material. When handled properly, they can complement conventional cytomorphology and expand the role of cytopathology in precision medicine. Until CSSs are fully validated, the information derived from them should be integrated with other findings.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1"},"PeriodicalIF":1.5,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148668043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Franzen-KIFA Handle up to Digital Cytopathology: The Long Story of Lymph Node Fine-Needle Aspiration Cytology. 从Franzen-KIFA手柄到数字细胞病理学:淋巴结细针穿刺细胞学的漫长故事。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-07-16 DOI: 10.1159/000553609
Elisabetta Maffei, Immacolata Cozzolino, Pio Zeppa, Alessandro Caputo
{"title":"From the Franzen-KIFA Handle up to Digital Cytopathology: The Long Story of Lymph Node Fine-Needle Aspiration Cytology.","authors":"Elisabetta Maffei, Immacolata Cozzolino, Pio Zeppa, Alessandro Caputo","doi":"10.1159/000553609","DOIUrl":"10.1159/000553609","url":null,"abstract":"<p><strong>Background: </strong>Lymph node fine-needle aspiration cytology (FNAC) has a history spanning more than a century, reflecting advances in cytology, pathology, and related technical disciplines. Lymph nodes were among the earliest targets of FNAC, which is now used to diagnose a broad spectrum of pathological processes, ranging from reactive conditions to lymphomas and metastases.</p><p><strong>Summary: </strong>To address these diverse settings, nearly all ancillary techniques used in pathology practice have been applied to lymph node FNAC, with their use tailored to the pathological process, the quality and quantity of diagnostic material, and the clinical context. Over time, this evolution has also led to the development of different technical procedures, diagnostic algorithms, and classification systems. Despite its achievements and potential, lymph node FNAC is still not universally accepted and remains subject to skepticism among some clinicians and criticism from some pathologists. In many aspects, lymph node FNAC represents a paradigm of clinical cytology, and its history reflects both the period in which it evolved and the environments in which it has been practiced. This review retraces the development of lymph node FNAC from the dawn of cytopathology to the present, highlighting its major advances, current role, and future perspectives.</p><p><strong>Key messages: </strong>Lymph node FNAC has evolved into a versatile diagnostic tool for reactive, neoplastic, and metastatic lymph node lesions. The integration of ancillary techniques, technical innovations, and standardized classification systems has substantially expanded its diagnostic capabilities. Understanding the historical evolution of lymph node FNAC provides insight into its current role, ongoing limitations, and future perspectives in modern cytopathology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-22"},"PeriodicalIF":1.5,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148468269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serous Fluid Cytopathology: Landmark Developments in Techniques, Terminology, and Clinical Application. 浆液细胞病理学:技术、术语和临床应用的里程碑式发展。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-07-16 DOI: 10.1159/000553613
Ashish Chandra, Ralf Heine, Leonie Wheeldon, Sinchita Roy-Chowdhuri, Merce Jorda, Claire W Michael, Guoping Cai
{"title":"Serous Fluid Cytopathology: Landmark Developments in Techniques, Terminology, and Clinical Application.","authors":"Ashish Chandra, Ralf Heine, Leonie Wheeldon, Sinchita Roy-Chowdhuri, Merce Jorda, Claire W Michael, Guoping Cai","doi":"10.1159/000553613","DOIUrl":"10.1159/000553613","url":null,"abstract":"<p><strong>Background: </strong>This invited review for the special issue is a celebration of the continued growth of knowledge in the field of serous fluid cytopathology.</p><p><strong>Summary: </strong>The review begins by addressing the value of cytological examination of the fluid samples in conjunction with clinical, radiological, and biochemical data interpreted by the treating physician. It then covers the advances in cytopreparatory techniques with special reference to existing and emerging ancillary techniques available to obtain maximal diagnostic, prognostic, and therapeutic information for the practice of precision medicine. The concept of mesothelioma as a cytological diagnosis has been made possible in recent years through clinical research and advocacy by experts and this has added value to serous fluid samples especially when this is the only sampling method available for a patient. Advances in the recommended repertoire of immunostains and a standardized approach through the use of diagnostic categories has been made possible by The International System for Reporting Serous Fluid Cytopathology. The reporting system has found application to other types of fluid samples, most recently, cerebrospinal fluid cytology, which will be included in the forthcoming edition of the terminology system and is introduced in this special issue.</p><p><strong>Key messages: </strong>The review charts a journey commemorating important landmarks in our current understanding of serous fluids in diagnostic cytopathology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-24"},"PeriodicalIF":1.5,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148468251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Immunohistochemical Biomarkers for Antibody-Drug Conjugate Therapy in Pulmonary Cytology. 肺细胞学中抗体-药物结合治疗的预测性免疫组织化学生物标志物。
IF 1.5 4区 医学
Acta Cytologica Pub Date : 2026-07-06 DOI: 10.1159/000553423
Md Ali Osama, Zarine Kamaluddin, Lukas Bubendorf, Deepali Jain
{"title":"Predictive Immunohistochemical Biomarkers for Antibody-Drug Conjugate Therapy in Pulmonary Cytology.","authors":"Md Ali Osama, Zarine Kamaluddin, Lukas Bubendorf, Deepali Jain","doi":"10.1159/000553423","DOIUrl":"10.1159/000553423","url":null,"abstract":"<p><strong>Background: </strong>The management of lung cancer has undergone a major transformation with the advent of precision oncology, where treatment decisions increasingly rely on tumor-specific biomarkers rather than morphology alone. In advanced-stage disease, pulmonary cytology specimens are often the only diagnostic material available. Cytological preparations are increasingly important in the workup of NSCLC. Cell blocks are among the available preparation methods that can be used for morphological evaluation and ancillary testing, including immunohistochemistry (IHC) and molecular studies. With advances in transcriptomic and proteomic profiling, several novel biomarkers have emerged beyond conventional lineage-specific markers, expanding the role of IHC in prognostication, prediction of therapeutic response and therapeutic selection. This has become particularly important in the era of antibody-drug conjugates (ADCs), which selectively target tumor-associated antigens while minimizing damage to normal tissue.</p><p><strong>Summary: </strong>Cytology preparations, in all their forms, have become increasingly important in the diagnostic and predictive evaluation of non-small cell lung carcinoma (NSCLC). IHC remains one of the most practical and widely accessible methods for biomarker assessment, particularly in resource limited settings. Several ADC-related biomarkers, including HER2, MET, TROP2, and HER3 have recently gained therapeutic relevance, with multiple targeted agents either approved or under active clinical investigation. In addition, emerging biomarkers such as MTAP deficiency further broaden the predictive biomarker landscape and can be reliably assessed using IHC. This review summarizes the current understanding and evolving data regarding immunohistochemical biomarkers in pulmonary cytology, with special emphasis on ADC-related markers and their application in cell block preparations. The biological rationale, diagnostic utility, therapeutic implications, interpretation criteria, and limitations of these biomarkers are discussed.</p><p><strong>Key messages: </strong>Various cytological preparations from pulmonary cytology specimens can be used for diagnostic and predictive biomarker testing in lung carcinoma. IHC-based evaluation of emerging biomarkers is increasingly important for guiding personalized therapy, particularly in the context of ADCs and targeted treatment strategies. A clear understanding of the interpretation and limitations of these biomarkers is essential for pathologists involved in thoracic cytopathology and precision oncology.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-11"},"PeriodicalIF":1.5,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148395370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书